Canakinumab cut gout attacks in CANTOS

AMSTERDAM – Post hoc analysis of data collected from the CANTOS trial showed that interleukin-1 blockade with canakinumab halved the rate of gout...

Conference Coverage

New agents may bring hope for SLE patients

SANDESTIN, FLA. – Dr. Michelle Petri describes promising drugs under investigation and goals for drug treatment for different patients with SLE....